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Does preoperative dipyridamole-thallium
scanning reduce 90-day cardiac
complications and 1-year mortality in
patients with femoral neck fractures
undergoing hemiarthroplasty?
Chin-Yi Liao1, Timothy L. Tan2, Yu-Der Lu1, Cheng-Ta Wu1, Mel S. Lee1 and Feng-Chih Kuo1*

Abstract
Background: This study aimed to evaluate the effect of dipyridamole-thallium scanning (DTS) on the rates of 90day cardiac complications and 1-year mortality in patients with a femoral neck fracture treated with
hemiarthroplasty.
Methods: Between 2008 and 2015, 844 consecutive patients who underwent cemented or cementless
hemiarthroplasty were identified from the database of a single level-one medical center. One-hundred and thirteen
patients (13%) underwent DTS prior to surgery, and 731 patients (87%) did not. Patient characteristics,
comorbidities, surgical variables, and length of the delay until surgery were recorded. A propensity score-matched
cohort was utilized to reduce recruitment bias in a 1:3 ratio of DTS group to control group, and multivariate logistic
regression was performed to control confounding variables.
Results: The incidence of 90-day cardiac complications was 19.5% in the DTS group and 15.6% in the control
group (p = 0.343) among 452 patients after propensity score-matching. The 1-year mortality rate (10.6% vs 13.3%, p
= 0.462) was similar in the two groups. In the propensity score-matched patients, utilization of DTS was not
associated with a reduction in the rate of 90-day cardiac complications (matched cohort, adjusted odds ratio [aOR]
= 1.32; 95% confidence interval [CI] 0.75–2.33, p = 0.332) or the 1-year mortality rate (aOR = 0.62; 95% CI 0.27–1.42,
p = 0.259). Risk factors for cardiac complications included an American Society of Anesthesiologists grade ≥ 3 (OR
3.19, 95% CI 1.44–7.08, p = 0.004) and pre-existing cardiac comorbidities (OR 5.56, 95% CI 3.35–9.25, p < 0.001). Risk
factors for 1-year mortality were a long time to surgery (aOR 1.15, 95% CI 1.06–1.25, p = 0.001), a greater age (aOR
1.05, 95% CI 1.00 to 1.10, p = 0.040), a low body mass index (BMI; aOR 0.89, 95% CI 0.81–0.98, p = 0.015), and the
presence of renal disease (aOR 4.43, 95% CI 1.71–11.46, p = 0.002).
(Continued on next page)
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Discussion: Preoperative DTS was not associated with reductions in the rates of 90-day cardiac complications or 1year mortality in patients with a femoral neck fracture undergoing hemiarthroplasty. The necessity for DTS should
be re-evaluated in elderly patients with femoral neck fractures, given that this increases the length of the delay until
surgery.
Level of evidence: Prognostic level III
Keywords: Dipyridamole-thallium scanning, Femoral neck fracture, Mortality, Cardiac complications,
Hemiarthroplasty

Introduction
Femoral neck fracture is a geriatric low-energy trauma
with an increasing incidence in Asia [1] and has profound economic and medical impacts worldwide [2, 3].
The standard treatment for displaced femoral neck fractures in geriatric patients is arthroplasty [4]; however,
patients may experience significant morbidity and mortality due to pre-existing cardiovascular comorbidities
and insult from surgery [5]. Therefore, it is common
practice to hold a preoperative consultation with internal
medicine doctors or anesthesiologists for risk stratification and treatment optimization.
Dipyridamole-thallium scanning (DTS), or 201scintigraphy, has been suggested as a method of preoperatively assessing cardiac risk in patients undergoing major
non-cardiac surgery. The American College of Cardiology
(ACC) and American Heart Association (AHA) guidelines
include DTS as one of the modalities for perioperative
cardiovascular evaluation prior to non-cardiac surgery [6,
7]. In terms of preoperative practice in other specialties,
for instance, Landesberg et al. [8] examined the use of
thallium scanning and selective coronary angiography
prior to major vascular therapy and reported a significant
improvement in the long-term outcome. Yin et al. [9] also
demonstrated that applying preoperative DTS can prevent
cardiac mortality and complications in patients undergoing parathyroidectomy. Hemiarthroplasty is classified as
intermediate cardiac risk procedure, with reported perioperative morbidity rates ranging from 1 to 5% according
to the ACC/AHA preoperative guidelines [6]. However,
there is minimal literature on whether this examination
results in any differences in outcomes in patients undergoing surgery for the treatment of a hip fracture.
The purpose of this study was to evaluate the correlations of DTS with the rates of 90-day cardiac complications and 1-year mortality in patients with a femoral
neck fracture treated with hemiarthroplasty. We hypothesized that if DTS reduces the risk of postoperative complications, or if further selective preoperative treatment
such as coronary intervention may be indicated in light
of the results of DTS, the rate of postoperative cardiac
complications may be reduced by balancing the bias in
these patients.

Materials and methods
Data source and patients

The Institutional Review Board (IRB) approved the study
protocol, and patient consent was waived by the IRB, as
all personal identifying information was removed from
the dataset and strict anonymity was maintained before
further analysis. The duration of IRB approval was from
August 2016 to October 2016, and privacy regulations
related to the research database in our institution were
adhered to in order to prevent confidential information
being utilized against medical ethics. We retrospectively
enrolled 968 consecutive patients undergoing hemiarthroplasty whose data were obtained from a trauma
database held at a single academic institution from January 2008 to December 2015. Raw data acquisition was
completed in 2 months; however, data completeness, reliability, organization details, and patient exclusions were
manually reviewed by 3 independent authors (CYL,
YDL, and CTW) to prevent observation bias. The inclusion criteria were patients with displaced femoral neck
fractures who were older than 60 years. Patients with a
non-displaced fracture, those aged under 60 years, and
those with multiple trauma, valgus impacted fracture,
pathologic fracture, or open fracture were excluded.
After application of the exclusion criteria, 844 patients
with displaced femoral neck fractures who underwent
cemented or cementless hemiarthroplasty were included
in this study.
All patients underwent a preoperative medical examination that included a resting electrocardiogram, chest
radiography and blood test. Following this screening,
they were seen by an anesthesiologist before surgery,
and a cardiology consultation was obtained if concerns
were raised by the anesthesiologist. The cardiologist or
physician evaluated the patients undergoing non-cardiac
surgery based on the 2007 ACC/AHA guidelines on
perioperative cardiovascular evaluation [6]. As per the
guidelines, routine screening with non-invasive stress
testing was not performed in patients undergoing lowrisk non-cardiac surgery; however, if the test results impacted on our decision-making, including canceling the
operation or changing the perioperative care, this testing
was arranged for patients with an elevated cardiac risk
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and a poor metabolic equivalent of task (MET < 4). If
the patient had an elevated cardiac risk but a functional
capacity greater than or equal to a MET of 4 without
symptoms, the planned surgery would proceed.
Patients were divided into two categories based on receipt of DTS. The control group included patients who
underwent surgery without DTS after consultation with
an anesthesiologist or cardiologist, while the study group
included patients who underwent DTS. Patients with abnormal scan results were further evaluated by a cardiologist with regard to coronary angiography intervention.
Indications for coronary angiography were based on
clinical findings, such as new or medically unstable angina, previous or recent myocardial infarction, or persistent angina. Stent implantation or balloon angioplasty
during angiography was performed if coronary arterial
stenosis was greater than 50%, multiple-vessel disease
was present, or left main coronary artery occlusion was
observed.
Variables of interest were extracted by electronic query
of medical records and reviewed manually. The following information was obtained: basic demographic data,
age, gender, body mass index (BMI), American Society
of Anesthesiologists (ASA) grade, and preoperative comorbidities, including ischemic heart disease, congestive
heart failure, valvular heart disease, cerebrovascular accident (CVA), diabetes, chronic obstructive pulmonary
disease (COPD), rheumatoid arthritis, liver disease, renal
disease, and a history of cancer (Table 1). In addition,
the duration from hospital presentation to surgery,
anesthesia type (regional or general), use of cemented or
cementless fixation, duration of surgery, and need for
transfusion were also obtained.
Surgical techniques

All hemiarthroplasty surgeries were performed through
the posterolateral approach in a lateral decubitus position. All patients were treated using a cemented or
cementless fixation technique by well-trained orthopedic
surgeons. The cemented or press-fit implants were
chosen based on preoperative imaging evaluation for
osteoporosis and intraoperative trial implantation at the
discretion of the treating surgeons. Intraoperative joint
capsules were approximated by sutures, and a closed
drainage tube was inserted, which was removed within
24–48 h. A partial weight-bearing rehabilitation program
was initiated by a physical therapist from postoperative
day 1. If a patient was unable to ambulate using a
walker, wheelchair ambulation was recommended.
Outcome measurement

The outcomes of this study included the rates of postoperative 90-day cardiac complications, 90-day mortality,
and 1-year mortality after the index hemiarthroplasty.
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ICD-9 codes were used to identify 90-day cardiac complications, including decompensated heart failure,
arrhythmia, sequelae of coronary artery disease, angina
pectoris, or acute myocardial infarction, while mortality
was defined as any death after the surgery. The mortality
data were obtained from the Health and Welfare Data
Science Center, Ministry of Health and Welfare
(HWDC, MOHW), who hold a set of healthcare-related
databases that provide information from over 30 departments and ministries, including the National Health Insurance Research Database (NHIRD). The NHIRD is an
administrative dataset derived from Taiwan’s universal
National Health Insurance program and contains records of the enrolled 99% of the Taiwanese population.

Statistical analysis

All variables were tested for normality using the
Kolmogorov-Smirnov test. Student’s t test was utilized
for normally distributed continuous variables, and the
Mann-Whitney U test was used for nonparametric data.
Fisher’s exact test or the chi-squared test was used for
categorical variables. Comparison was performed before
and after applying propensity score-matching.
Propensity score-matched analysis uses a propensity
score calculated from covariate data to match patients
from different study groups. The technique is often
applied to eliminate selection bias in orthopedic observational studies [10]. We employed this technique
(1:3 ratio of DTS group to control group) with a logistic regression model to adjust the covariates, including basic demographic data (age, gender, BMI,
and ASA grade), preoperative comorbidities (all cardiac comorbidities, CVA, diabetes, COPD, rheumatoid
disease, liver disease, renal disease, and cancer history), surgical variables (anesthesia type, use of a
cemented or cementless stem, duration of surgery,
and transfusion), and time interval from hospital admission to surgery, in order to decrease the differences in baseline conditions between groups and to
minimize selection bias in the performance of DTS.
Univariate and multivariate logistic regression analyses
were also conducted to determine whether DTS was
an independent factor affecting the rates of 90-day
cardiac complications and 1-year mortality after
adjusting for the confounding factors listed above.
Odds ratios (ORs) with 95% confidence intervals (CIs)
were calculated, and a p value of less than 0.05 was
taken to indicate statistical significance. All statistical
analyses were performed using Statistical Package for
Social Science (SPSS) version 22 software (SPSS Inc.,
IBM, Armonk, NY, USA) and NCSS Statistical Analysis and Graphics software (NCSS, LLC, Kaysville,
UT, USA).
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Table 1 Baseline demographic data, surgical factors, and length of stay in unmatched and matched patients who did and did not
undergo a dipyridamole-thallium scan
Non-thallium scan group
Thallium scan group (n = 113) Unmatched cohort (n = 731) p value Matched cohort (n = 339) p value
Age, mean ± SD, years

79.8 ± 8.3

74.7 ± 11.3

Sex, n (%)

< 0.001 79.9 ± 8.3

0.901

0.590

0.908

Male

37 (32.7)

221 (30.2)

109 (32.2)

Female

76 (67.3)

510 (69.8)

230 (67.8)

22.6 ± 3.5

22.7 ± 4.1

Body mass index, mean ± SD, kg/m2
ASA grade, n (%)

0.774

22.5 ± 3.9

< 0.001

0.980
0.010

1

0 (0.0)

11 (1.5)

2 (0.6)

2

5 (4.4)

185 (25.3)

57 (16.8)

3

106 (93.8)

523 (71.5)

270 (79.6)

4

1 (0.9)

10 (1.4)

8 (2.4)

Delay until surgery, mean ± SD, days

7.0 ± 12.4

2.4 ± 3.3

< 0.001 3.7 ± 4.2

< 0.001

Delay until surgery > 2 days, n (%)

110 (97.3)

352 (48.2)

< 0.001 127 (37.5)

< 0.001

25 (22.1)

56 (7.7)

< 0.001 47 (13.9)

0.038

Preoperative comorbidities, n (%)
Ischemic heart disease
CHF

6 (5.3)

27 (3.7)

0.431

20 (5.9)

0.816

Valvular heart disease

11 (9.7)

18 (2.5)

0.001

17 (5.0)

0.071

CVA

11 (9.7)

76 (10.4)

0.829

34 (10.0)

0.928

Diabetes

44 (38.9)

216 (29.5)

0.044

123 (36.3)

0.613

COPD

13 (11.5)

53 (7.3)

0.117

31 (9.1)

0.464

RA

1 (0.9)

14 (1.9)

0.440

3 (0.9)

1.000

Liver disease

2 (1.8)

37 (5.1)

0.121

7 (2.1)

1.000

Renal disease

14 (12.4)

59 (8.1)

0.129

37 (10.9)

0.668

Cancer

4 (3.5)

48 (6.6)

0.213

12 (3.5)

1.000

Anesthesia type, n (%)

0.071

0.597

General

94 (83.2)

651 (89.1)

289 (85.3)

Regional

19 (16.8)

80 (10.9)

50 (14.7)

65 (57.5)

297 (40.6)

< 0.001 199 (58.7)

0.826

132.3 ± 44.5

0.142

0.930

Cemented stem, n (%)

Time in surgical theater, mean ± SD, min 125.9 ± 36.3

125.5 ± 33.8

ASA American Society of Anesthesiologists, CHF congestive heart failure, CVA cerebrovascular accident, COPD chronic obstructive pulmonary disease, RA
rheumatoid arthritis, SD standard deviation

Results
There were several baseline differences between the patients who underwent preoperative DTS and those who
did not before propensity score-matching. The patients
who underwent DTS were of an older age (p < 0.001)
and a higher ASA grade (p < 0.001), and higher proportions of those patients had ischemic heart disease (22.1%
vs 7.7%, p = 0.001), valvular heart disease (9.7% vs 2.5%,
p = 0.001), and diabetes mellitus (38.9% vs 29.5%, p =
0.044). In addition, cemented hemiarthroplasty was
more common in these patients (57.5% vs. 40.6%, p <
0.001). Furthermore, patients who underwent DTS had
an average wait of 4.6 days longer to receive surgery (7.0
± 12.4 days vs. 2.4 ± 3.3 days, p < 0.001).

After performing propensity score-matching, patients
who underwent DTS had a higher ASA grade (p = 0.01),
and a higher proportion of those patients had ischemic
heart disease (p = 0.038). Further standardized difference
analysis of ASA grade showed a reduction from 62.8% to
32.1%, while the standardized difference of ischemic
heart disease was reduced from 36.0 to 18.0%. All other
covariates and comorbidities were statistically balanced
after each examination of the Student t test and chisquare test results. Patients who underwent DTS still
had a longer preoperative delay until surgery (7.0 ± 12.4
days vs. 3.7 ± 4.2 days, p < 0.001).
In our study, the 90-day cardiac complications observed were as follows: 2 patients (0.2%) with angina
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pectoris; 32 (3.7%) with symptomatic heart failure; 60
(7.1%) with cardiac arrhythmia, including 53 with atrial
fibrillation with rapid ventricular response, 5 with right
bundle branch block, and 2 with episodic paroxysmal
supraventricular tachycardia (asymptomatic sinus bradycardia or tachycardia; first-degree atrioventricular block
was excluded); 1 (0.1%) with a history of thoracic aortic
dissection; and 6 (0.7%) with acute myocardial infarction.
After propensity score-matching, the incidence of 90day cardiac complications was 19.5% in the DTS group
and 15.6% in the control group (p = 0.343).
The 90-day mortality (0.9% vs. 1.2%, p = 0.795) and 1year mortality rates (10.6% vs 13.3%, p = 0.462) were
similar between the two groups (Fig. 1). Furthermore,
we regarded the 23 patients with positive DTS findings
as a subgroup and compared this group with the
remaining 90 patients with negative DTS findings and
the 339 patients in the control group. The 1-year mortality rate was still not significantly different between the
three subgroups according to the results of the chisquare test (p = 0.706).
The correlations of DTS with the rates of 90-day cardiac complications, 90-day mortality, and 1-year mortality are depicted in Table 2. Multivariate analysis revealed
no significant associations of DTS with the rates of 90day cardiac complications (adjusted OR [aOR] = 1.44;
95% CI 0.71 to 2.91, p = 0.309), 90-day mortality (aOR =
9.80; 95% CI 0.23 to 424.80, p = 0.235), or 1-year mortality (aOR = 0.54 95% CI 0.24 to 1.20, p = 0.128). Analysis
of the propensity score-matched cohort also confirmed
no significant differences in terms of the correlations of
DTS with the rates of 90-day cardiac complications
(aOR = 1.32; 95% CI 0.75 to 2.33, p = 0.332), 90-day
mortality (aOR = 0.75; 95% CI 0.08 to 6.71, p = 0.797),
or 1-year mortality (aOR = 0.622, 95% CI 0.27 to 1.42, p
= 0.259). We performed further subgroup evaluation of

Fig. 1 Rates of 90-day cardiac complications, 90-day mortality, and
1-year mortality in patients who did and did not undergo a
dipyridamole-thallium scan after propensity score-matching
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cardiac complications in order to assess the correlations
of DTS with postoperative unstable angina and acute
myocardial infarction, and no statistically significant differences between the DTS group and the non-DTS
group were observed (p = 0.437 and 0.272, respectively).
Independent risk factors for postoperative 90-day cardiac complications included an ASA grade ≥ 3 (OR 3.19,
95% CI 1.44 to 7.08, p = 0.004) and pre-existing cardiac
comorbidity (OR 5.56, 95% CI 3.35 to 9.25, p < 0.001) in
the multivariate analysis (Table 3). Independent risk factors for 1-year mortality were a long delay until surgery
(OR 1.15, 95% CI 1.06 to 1.25, p = 0.001), an older age
(OR 1.05, 95% CI 1.00 to 1.10, p = 0.040), a low BMI
(OR 0.89, 95% CI 0.81 to 0.98, p = 0.015), and the presence of renal disease (OR 4.43, 95% CI 1.71 to 11.46, p =
0.002) in the multivariate analysis (Table 4).
Of the 113 patients who underwent DTS, 90 (79.7%)
had negative findings and 23 (20.3%) were found to have
reversible myocardial ischemia. According to the followup records of these 23 patients, 10 (8.8%) underwent
cardiac catheterization, but only 3 (2.7%) underwent a
primary coronary intervention (PCI) with stenting, using
either bare-metal or drug-eluting stents, or balloon
angioplasty; the 7 patients (6.2%) who did not undergo a
PCI during cardiac catheterization were treated in accordance with the judgment of a cardiologist. All of the
10 patients who underwent cardiac catheterization or
further PCI received surgery eventually, and none of
these 10 patients had postoperative cardiac complications or died within 90 days. Of the 13 patients (11.5%)
who underwent DTS and who did not undergo cardiac
catheterization, one developed postoperative myocardial
infarction, but soon recovered after PCI with stenting;
the follow-up records of this patient for 1 postoperative
year were examined, and no further cardiac morbidity or
mortality was documented (Fig. 2).
All of the 23 patients in the DTS group with reversible
myocardial ischemia were alive at 90 days postoperatively.
Three patients (13%) who did not receive a cardiac
catheterization were dead within 1 year after surgery. One
of those patients had probable reversible myocardial ischemia, and the leading cause of death was respiratory failure
after a benzodiazepine overdose. The second patient had
three-vessel coronary artery disease, atrial fibrillation and
a history of decompensated heart failure post-mechanical
ventilation 1 year prior to surgery, and the leading cause
of death was decompensated heart failure. There was no
evidence of new onset of myocardial ischemia in the second patient according to the documented levels of cardiac
enzymes and the results of electrocardiography. The final
patient had an equivocal result in the thallium test, and
the leading cause of death was pneumonia. In no case of
mortality was there significant evidence of a relationship
with myocardial ischemia.
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Table 2 Univariate and multivariate logistic regression models evaluating the associations of dipyridamole-thallium scan with the
rates of 90-day cardiac complications, 90-day mortality, and 1-year mortality
Outcome

Unmatched cohort

Matched cohort

Unadjusted OR (95% CI)

p value

Adjusted OR (95% CI)

p value

Adjusted ORb (95% CI)

p value

Overall 90-day cardiac complications

1.86 (1.11–3.13)

0.019

1.44 (0.71–2.91)

0.309

1.32 (0.75–2.33)

0.332

Unstable angina

6.52 (0.41–104)

0.186

4.26 (0.12–154)

0.429

3.02 (0.19–48.1)

0.437

Acute myocardial infarction

3.28 (0.59–18.1)

0.174

2.83 (0.38–21.2)

0.310

3.04 (0.42–21.3)

0.272

90-day mortality

0.92 (0.11–7.58)

0.941

9.80 (0.23–424.8)

0.235

0.75 (0.08–6.71)

0.797

1-year mortality

1.09 (0.57–2.08)

0.799

0.54 (0.24–1.20)

0.128

0.62 (0.27–1.42)

0.259

a

a

Adjusted for age, sex, body mass index, American Society of Anesthesiologists (ASA) grade, preoperative comorbidities (ischemic heart disease, congestive heart
failure, valvular heart disease, cerebrovascular accident, diabetes, chronic obstructive pulmonary disease, rheumatoid arthritis, liver disease, renal disease, and
cancer history), surgical variables (anesthesia and cemented stem, operative duration, and transfusion), and duration to surgery
b
Adjusted for ASA grade and ischemic heart disease
OR odds ratio, CI confidence interval

Discussion
The results of our study suggested that the rate of 90day cardiac complications was still high despite the use
of DTS (19.5% vs. 15.6%, Fig. 1). Utilization of preoperative DTS was not significantly associated with a change
in the rate of 90-day overall cardiac complications (OR
= 1.32; 95% CI 0.75 to 2.33; p = 0.332, Table 2) after
controlling the confounders. Further subgroup evaluation of patients with postoperative unstable angina and
acute myocardial infarction was performed, which also
showed no statistically significant differences between
the two groups (p = 0.437 and 0.272, respectively). We
found that patients with an ASA grade ≥ 3 and those
with pre-existing cardiac comorbidities (ischemic heart
disease, congestive heart failure, and valvular heart disease) were associated with an increased risk of 90-day
cardiac complications. Furthermore, among the patients
who underwent DTS, only one (4.3%) had myocardial infarction after surgery, and no mortality was observed
within 90 days postoperatively. We examined the records
of the 23 patients with positive DTS findings for up to 1
year post-surgery; of these 23 patients, 3 who did not
undergo cardiac catheterization were dead, but the leading causes were not directly related to myocardial ischemia. Our results demonstrated that the performance of
DTS was not associated with a reduction in the rate of
cardiac complications.
DTS was not found to be associated with a change in
the 90-day mortality rate (aOR = 0.75; 95% CI 0.08 to

6.71; p = 0.797) or the 1-year mortality rate (aOR = 0.62,
95% CI 0.27 to 1.42; p = 0.259) (Table 2) after controlling the confounders in this study. We assumed that
DTS may lead to fewer cardiac complications and alter
the mortality rate in light of potential improvement in
the selection of the most suitable coronary interventions
after DTS. However, the mortality rate in the patients
with positive DTS findings was not statistically significantly different to that in the patients with negative DTS
findings or the control group (p = 0.706). The benefit of
DTS was not as strong as has been demonstrated in
studies examining other specialties, such as thyroid and
cardiovascular surgery [8, 9].
A delay in performing surgery by 48 h was not an independent factor related to the rate of 90-day complications according to the results of multivariate logistic
regression (OR1.50, 95% CI 0.76 to 2.95, p = 0.243);
however, it was significantly related to the rate of 90-day
cardiac complications according to Pearson chi-square
analysis (p = 0.035). These results may imply that delayed surgery did not affect patient outcomes directly
but was a reflection of the comorbidities that contributed to postoperative complications. Thus, in patients
with cardiac comorbidities or an ASA score of 3 or 4,
surgery could have been delayed in order to allow improvement in the general condition of the patient. It is
difficult to set precise cut-off points to define early and
Table 4 Results of multivariate logistic regression regarding 1year mortality

Table 3 Results of multivariate logistic regression regarding 90day cardiac complications
Beta
Standard OR
coefficient error
ASA grade ≥ 3

95% CI

p value

Beta
coefficient

Standard
error

OR

95% CI

p value

Delay until
surgery, days

0.14

0.42

1.15

1.06 to 1.25

0.001

1.16

0.41

3.19 1.44 to 7.08 0.004

Age, years

0.05

0.02

1.05

1.00 to 1.10

0.040

Cardiac comorbidities 1.72

0.26

5.56 3.35 to 9.25 < 0.001

Body mass
index, kg/m2

-0.11

0.05

0.89

0.81 to 0.98

0.015

Renal disease

1.49

0.49

4.43

1.71 to 11.46

0.002

Cardiac comorbidities included ischemic heart disease, congestive heart
failure, and valvular heart disease
OR odds ratio, CI confidence interval, ASA American Society
of Anesthesiologists

OR odds ratio, CI confidence interval
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Fig. 2 Flowchart showing the selection process of patients and the further decision-making in the two groups, categorized according to
performance of a dipyridamole-thallium scan
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delayed surgery, but generally, the optimal timing might
be considered between 12 and 48 h after presentation at
the hospital based on current evidence [11].
It is worth mentioning that a long delay until surgery
(OR 1.15, 95% CI 1.06 to 1.25, p = 0.001) was associated
with the 1-year mortality rate in our study. Several previous studies found that a prolonged duration until surgery (≥ 48 h) for hip fractures may increase the 30-day
and 1-year mortality rates [12, 13]. However, it is a frequent practice that preoperative consultation with another service is obtained for risk stratification and
medical optimization. While the goal is to make a decision to proceed immediately or medically optimize the
patient first, the process of preoperative medical evaluation usually takes 1 to 2 days before the patient can be
taken to surgery [14]. Among the common preoperative
examinations, DTS may take longer to organize, as it is
often dependent on scanner availability and time of day
[15–18], and an average delay of 4 days was observed at
our institution.
Being overweight is generally considered a risk factor
related to high morbidity and mortality, but the results
of recent studies suggested that obese patients may have
had a lower mortality rate after hip fracture in old patients with comorbidities. This phenomenon is termed
the “obesity paradox” in the literature [19], but there is
debate over the evidence and physiology. Hedstrom
et al. [20] assumed that there exists a prolonged catabolic response after stress suffered following a hip fracture, and patients with a higher BMI may have a greater
metabolic reserve to enable them to better endure this
stress, which was also found to be the case in critical illness [21]. The results of our study suggested a higher 1year mortality rate in patients of low BMI, which was
compatible with previous literature (OR 0.89, 95% CI
0.81 to 0.98, p = 0.015), and this indicates the importance of nutritional support, especially in patients with
cachexia.
The incidence of hip fracture is high among patients
with renal failure due to osteoporosis and osteodystrophy, and there is evidence to suggest that patients with
chronic kidney disease (CKD) have a higher mortality rate
after hip fracture in the elderly [22]. Postoperative care of
CKD patients is always challenging due to difficulty in fluid
management, higher comorbidity, and catastrophic complications after acute exacerbation of renal failure. Our research indicated a higher 1-year mortality rate in patients
with renal disease (OR 4.43, 95% CI 1.71 to 11.46, p =
0.002), and a multi-discipline protocol should be established in the future, as these patients may not participate in
standard rehabilitation and osteoporosis treatment.
Ricci et al. [23] demonstrated that preoperative cardiac
testing (DTS, echocardiography, and cardiac catheterization)
did not change the management of perioperative orthopedic
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surgery or medical therapy in elderly patients with hip fractures but did incur a huge cost of over $47 million annually
in the USA; patients undergoing cardiac testing had a delay
to surgery on average 3.3 days, which was 1.4 days greater
than those who did not. Multiple studies have also demonstrated that preoperative cardiac testing with echocardiography delays surgery without a significant change in
preoperative cardiac medications or anesthesia [14, 24–26].
In addition, the cost of a thallium test is 261.22 dollars at our
institution. Compared with previous studies, we included
more patients in our study; moreover, we performed propensity score analysis to control possible group differences in patients’ background conditions and reduce the effect of
selection bias. We also analyzed the independent factors related to postoperative cardiac complications and the 1-year
mortality rate. It is worth mentioning that we extracted mortality data from the records of the Health and Welfare Data
Science Center, which included over 30 medical institutions
and over 99% of the population of Taiwan. Accordingly, our
mortality data were reliable, and this strengthened the power
of the analysis.
It is rational to consider that perioperative cardiac assessment could lead to safer surgery and fewer cardiac
complications. However, the results of previous studies
did not indicate increased benefit in cases of geriatric
hip trauma. Thus, we suppose that over-screening may
occur in daily practice. Currently, during preoperative
assessment by a cardiologist following the ACC/AHA
guidelines, patients who have a functional capacity of < 4
MET require further evaluation, which is arbitrary and
subjective and may lead to over-diagnosis and incorrect
indications of cardiac examinations. Vigoda et al. [27]
performed a study of 548 anesthesiologist residents nationwide and examined their judgment in different scenarios. Fewer than half of the participants adhered to
correct practice in accordance with standard care as set
down in the 2007 ACC/AHA guidelines. We also assumed that the evolving minimally invasive technique of
hemiarthroplasty with a reduced surgical duration, in
conjunction with postoperative early rehabilitation with
mechanical/pharmaceutic thromboembolism prophylaxis, would result in a lower incidence of postoperative
morbidity as compared with the same surgery decades
ago. There may exist an imbalance between performance
of an expensive nuclear imaging test, which delays surgery for up to 4 days, and its clinical benefit.
Highly selective coronary angiography and interventions are no doubt helpful in terms of decreasing postoperative morbidity/mortality. In our study, 113 patients
underwent DTS, but only 10 received coronary angiography, and only 3 of those 10 patients required interventions with a stenting procedure (2.7%). Thus, we
identified a low rate of selective angiography with PCI
after obtaining the results of DTS, which may account
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for a decreased clinical benefit of testing. The thallium
scan has a questionable negative predictive value in patients with “balanced ischemia” due to global myocardial
ischemia leading to poor interpretation of a relative perfusion defect in affected segments, which is a common
phenomenon in nuclear imaging [28–30].
It is necessary to develop a better cardiac assessment
tool with greater specificity that is less time-consuming
to perform and has a better negative predictive value.
Focused transthoracic echocardiography, or goaldirected focused cardiac ultrasound (FoCUS), has garnered interest for its use in perioperative assessment
under specific conditions, especially for urgent surgery,
due to its availability, portability, and time-saving property [31, 32]. Canty et al. [33] performed a prospective
observational study of 99 patients who had suspected
cardiac disease or were older than 65 years, in which
preoperative focused echocardiography was performed
by an anesthesiologist. In that study, this examination
allowed identification of 64% of patients with cardiac
disease, and clinical measures including referral to a cardiologist, change to the type of surgery performed, or intraoperative optimization were implemented in 36% of
patients. However, there has been no comparative study
of formal stress echocardiography and bedside FoCUS,
and there remains uncertainty around the appropriate
level of experience required in order to decrease the
number of false negatives. Currently, there is no consensus with regard to a thallium scan substitute, but computed tomographic angiography (coronary CTA) has
been noted to be useful. Huang et al. [34] investigated
the value of coronary CTA in non-cardiac surgeries and
found that this examination yielded improved perioperative risk stratification with a low rate of major cardiac
events, high specificity, and good negative predictive
value. The risk of a major cardiac event was reported to
be 14% in patients with significant CTA findings [34].
Future research involving prospective, randomized allocation of patients is warranted to minimize selection bias
and group differences.
There were several limitations of this study that should
be considered. Most notably, there may have been selection bias, as DTS was performed in high-risk patients
who were likely inherently subject to a higher risk of 90day cardiac complications. We attempted to balance the
baseline patient condition and control for potential confounders, but the DTS group still had a higher ASA
grade, higher rates of ischemic heart disease and delayed
surgery, even further standardized difference analysis
showed reduction of imbalance between groups. Second,
the decision to utilize DTS was made by different cardiologists, and thus there may be some variation in patient
stratification and the cardiologists’ willingness to order
additional cardiac tests. Third, we focused on the rates
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of 90-day cardiac morbidity and 1-year mortality and
thus did not account for any complications that may
have occurred beyond that follow-up duration.

Conclusion
Preoperative DTS was not associated with reductions in
the rates of 90-day cardiac complications and 1-year
mortality in patients with a femoral neck fracture undergoing cemented or cementless hemiarthroplasty. The patients in whom DTS was performed underwent surgery
4 days later on average than the patients who did not,
with no significant clinical benefit in terms of the rates
of 90-day cardiac complications and 1-year mortality.
Given the results of this study and those reported in
existing literature, we propose that routine DTS in patients with an isolated femoral neck fracture should not
be performed. We instead suggest that it is important to
consider the patient’s preoperative cardiovascular comorbidity, underlying disease, and functional status during the preoperative assessment.
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